{
    "clinical_study": {
        "@rank": "87470", 
        "acronym": "GLUCONEO", 
        "arm_group": [
            {
                "arm_group_label": "Adult with neonatal diabetes", 
                "description": "Adult with neonatal diabetes (before 1 year ) and need for insulin"
            }, 
            {
                "arm_group_label": "non diabetic adults with a relative with neonatal diabetes"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to evaluate Beta cells in patients with a neonotal\n      diabetes linked to a genetic abnormality Metabolic caracteristics will described using a\n      transversal cohort study."
        }, 
        "brief_title": "Future of Beta Cells in Adults With Genetic Abnormality Behind Neonatal Diabetes", 
        "condition": "Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age : 18 \u00e0 65 year\n\n          -  diabetic patient with a neonatal diabetis (before 1 year old) and need for insuline\n             or patient with a relative having neonatal diabetis\n\n        Exclusion Criteria:\n\n        Diab\u00e8te induit (m\u00e9dicaments - ex cortico\u00efdes) ou syndromique\n\n          -  infection\n\n          -  cancer\n\n          -  pegnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "diabetic people"
            }
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02072551", 
            "org_study_id": "GLUCONEO"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "jean-fran\u00e7ois.gautier@sls.aphp.fr", 
                "last_name": "Jean-Fran\u00e7ois GAUTIER, MD PHD", 
                "phone": "+33 1 42 49 96 87"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75010"
                }, 
                "name": "Hopital Siant-louis"
            }, 
            "investigator": {
                "last_name": "Jean-Fran\u00e7ois GAUTIER, MD PHD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "2", 
        "official_title": "Devenir au Long Cours de la Cellule b\u00eata Chez Les Adultes Porteurs d'Anomalies g\u00e9n\u00e9tiques \u00e0 l'Origine du Diab\u00e8te N\u00e9onatal", 
        "overall_contact": {
            "email": "jean-fran\u00e7ois.gautier@sls.aphp.fr", 
            "last_name": "Jean-Fran\u00e7ois GAUTIER, MD PhD", 
            "phone": "+33 1 42 49 96 87"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mean insulin secretion output", 
            "safety_issue": "No", 
            "time_frame": "Week after inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02072551"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "insulin secretion outout after arginine perfusion", 
                "safety_issue": "No", 
                "time_frame": "during hospitalisation (3 days)"
            }, 
            {
                "measure": "sensitivity to insulin", 
                "safety_issue": "No", 
                "time_frame": "during hospitalisation (3 days)"
            }, 
            {
                "measure": "glucago secretion output", 
                "safety_issue": "No", 
                "time_frame": "during hospitalisation (3 days)"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}